The pathogenesis of tuberculosis: The early infiltrate of post-primary (adult pulmonary) tuberculosis: A distinct disease entity

Frontiers in Immunology

Volumn 9, Issue SEP, 2018, Pages

  Hunter, Robert L ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Human; Lung; Pathogenesis; Pathology; Post primary; Tuberculosis; X ray

Indexed keywords

CLINICAL RESEARCH; DISEASE COURSE; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; IMMUNE STATUS; MYCOBACTERIUM TUBERCULOSIS; ONSET AGE; ORGAN DISTRIBUTION; PATHOGENESIS; POSTPRIMARY TUBERCULOSIS; REVIEW; TISSUE INJURY; X RAY; ADAPTIVE IMMUNITY; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG TUBERCULOSIS; MICROBIOLOGY; PATHOGENICITY; TIME FACTOR; TUBERCULOSIS; VIRULENCE;

ADAPTIVE IMMUNITY; ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TIME FACTORS; TUBERCULOSIS; TUBERCULOSIS, PULMONARY; VIRULENCE;

EID: 85054461572     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.02108     Document Type: Review

References (75)

1. Scully T. Tuberculosis. Nature (2013) 502:S1. doi: 10.1038/502S1a
2. Lee RS, Radomski N, Proulx JF, Levade I, Shapiro BJ, McIntosh F, et al. Population genomics of Mycobacterium tuberculosis in the Inuit. Proc Natl Acad Sci USA. (2015) 112:13609–14. doi: 10.1073/pnas.1507071112
3. Huang L, Russell DG. Protective immunity against tuberculosis: what does it look like and how do we find it? Curr Opin Immunol. (2017) 48:44–50. doi: 10.1016/j.coi.2017.08.001
4. Kaufmann SH, Evans TG, Hanekom WA. Tuberculosis vaccines: time for a global strategy. Sci Transl Med. (2015) 7:276fs278. doi: 10.1126/scitranslmed.aaa4730
5. Andersen P, Woodworth JS. Tuberculosis vaccines–rethinking the current paradigm. Trends Immunol. (2014) 35:387–95. doi: 10.1016/j.it.2014.04.006
6. Nunes-Alves C, Booty MG, Carpenter SM, Jayaraman P, Rothchild AC, Behar SM. In search of a new paradigm for protective immunity to TB. Nat Rev Microbiol. (2014) 12:289–99. doi: 10.1038/nrmicro3230
7. Anonymous. An International Roadmap for Tuberculosis Research: Towards a World Free of Tuberculosis. Stop TB Partnership; World Health Organization (2011).
8. Fauci AS, Eisinger RW. Reimagining the research approach to tuberculosis(dagger). Am J Trop Med Hyg. (2018) 98:650–2. doi: 10.4269/ajtmh.17-0999
9. Canetti G. Biology of the mycobacterioses. Pathogenesis of tuberculosis in man. Ann N Y Acad Sci. (1968) 154:13–8. doi: 10.1111/j.1749-6632.1968.tb16691.x
10. Pinner M. Pulomonary Tuberculosis in the Adult. Its Fundamental Aspects. Springfield, IL: Charles C Thomas (1945).
11. Laennec R. A Treatise on Diseases of the Chest in Which They Are Described According to Their Anatomical Characters, and Their Diagnosis Established on a New Principle by Means of Acoustick Instruments. (reprinted 1979 by The Classics of Medicine Library. Birmingham AL). London: TandG Underwood (1821).
12. Bennett J. H. The Pathology and Treatment of Pulmonary Tuberculosis. Philadelphia, PA: Blanchard and Lea (1854).
13. Rich A. The Pathogenesis of Tuberculosis, 2nd Edn. Springfield, IL: Charles C Thomas (1951).
14. Cornil V, Ranvier L. Part III, Section I Chapter II. Pathological histology of the respiratory apparatus. In: A Manual of Pathological Histology Translated with Notes and Additions by EO Shakespeare and JHC Simms. Philadephia, PA: Henry C Lea (1880). P. 394–445.
15. Canetti G. The Tubercle Bacillus in the Pulmonary Lesion of Man. Histobacteriology and Its Bearing on the Therapy of Pulmonary Tuberculosis. New York, NY: Springer Publishing Compani Inc. (1955).
16. Medlar EM. The behavior of pulmonary tuberculous lesions; a pathological study. Am Rev Tuberc. (1955) 71:1–244.
17. Powell RD. Chapter IPathology, I. (Available on Google Books). In: On Consumption and on Certin Diseases of Lungs and Pleura. (London: H. K. Lewis) (1876). P. 291.
18. Osler W, McCrae T. Chapter XXI, tuberculosis. In: The Principles and Practice of Medicine. 9th ed. New York, NY; London: Appleton D and Company (1921). p. 184–255.
19. Kayne GG, Pagel W, O'Shaughenessy L. Pulmonary Tuberculosis, Pathology, Diagnosis and Management. London. Oxford University Press (1939).
20. Pagel W, Simmonds F, MacDonald N, Nassau E. Chapter 3. The morbid anatomy and histology of tuberculosis, an introduction in simple terms. In: Pulmonary Tuberculosis, Bacteriology, Pathology, Management, Epidemiology and Prevention. London: Oxford University Press (1964). p. 36–63.
21. Gunn FD. Tuberculosis. In: Anderson WAD, editor. Pathology. 2nd ed. St. Louis, MI: C. V Mosby Company (1953). P. 234–62.
22. Scriba TJ, Penn-Nicholson A, Shankar S, Hraha T, Thompson EG, Sterling D, et al. Other members of the. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. PLoS Pathog. (2017) 13:e1006687. doi: 10.1371/journal.ppat.1006687
23. Green TH. Introduction to Pathology and Morbid Anatomy. Philadelphia, PA: Henry C Lea's Son and Co. (1884).
24. Fishberg M. Pulmnary Tuberculosis: Third Edition, Revised and Enlarged. New York, NY, Philadephia, PA: Lee and Lebiger (1922).
25. Opie EL. Recognition and control of tuberculosis of childhood. Am J Public Health Nat Health (1933) 23:305–15. doi: 10.2105/AJPH.23.4.305-b
26. Hunter RL, Jagannath C, Actor JK. Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. Tuberculosis (2007) 87:267–78. doi: 10.1016/j.tube.2006.11.003
27. Hunter RL, Olsen MR, Jagannath C, Actor JK. Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann Clin Lab Sci. (2006) 36:371–86.
28. Hunter RL. Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis (2011) 91:497–509. doi: 10.1016/j.tube.2011.03.007
29. Hunter RL, Actor JK, Hwang S, Karev V, Jagannath C. Pathogenesis of post primary tuberculosis: immunity and hypersensitivity in the development of cavities. Ann Clin Lab Sci. (2014) 44:365–87.
30. Hunter RL. Tuberculosis as a three-act play: a new paradigm for the pathogenesis of pulmonary tuberculosis. Tuberculosis (2016) 97:8–17. doi: 10.1016/j.tube.2015.11.010
31. Gunn FD. Tuberculosis. In: Anderson WAD, editor. Pathology, 4th ed. St Louis, MI: C. V. Mosby Company (1961). p. 243–63.
32. Crooke GF. Post Gaduate Lectures on The Medical Pathology of Tuberculosis, (Pulmonry Tuveculosais and Tubecular Phthisis). Strand; London: Bailliere, Tindall & Coc (facsimilepublisher.com); King William Street (1891).
33. Kerley P. Assmann's Focus. Br J Tuberculosis (1935) 29:19–25. doi: 10.1016/S0366-0850(35)80073-2
34. Amberson JB. A retrospect of tuberculosis: 1865-1965. Am Rev Respir Dis. (1966) 93:343–51.
35. Opie E, McPhedran F. The contagion of tuberculosis. Am Rev Tuberculosis XIV (1926) 14:347–419.
36. Dunham K. The pathological anatomy of pulmonary tuberculosis as recorded by stereoscopic radiograms of the chest; and the value of this knowledge in the care of the tuberculous patient. Proc R Soc Med. (1927) 21:61–5.
37. Kayne GG. Origin, diagnosis, and management of early bronchogenic tuberculosis. Br Med J (1941) 2:152, 154–8.
38. Im JG, Itoh H, Shim YS, Lee JH, Ahn J, Han MC, et al. Pulmonary tuberculosis: CT findings–early active disease and sequential change with antituberculous therapy. Radiology (1993) 186:653–60. doi: 10.1148/radiology.186.3.8430169
39. Skoura E, Zumla A, Bomanji J. Imaging in tuberculosis. Int J Infect Dis. (2015) 32:87–93. doi: 10.1016/j.ijid.2014.12.007
40. Ziemele B, Ranka R, Ozere I. Pediatric and adolescent tuberculosis in Latvia, 2011-2014: case detection, diagnosis and treatment. Int J Tuberc Lung Dis. (2017) 21:637–45. doi: 10.5588/ijtld.16.0270
41. Ankrah AO, Glaudemans A, Maes A, Van de Wiele C, Dierckx R, Vorster M, et al. Tuberculosis. Semin Nucl Med. (2018) 48:108–30. doi: 10.1053/j.semnuclmed.2017.10.005
42. Kerley P. Discussion on the early diagniosis of pulmonary tuberculosis. Peoc Roy Soc Med Sect Med XXVII (1933) 27:164–7.
43. Dunham HK, Skavlem JH. X-ray observations of the pathogenesis of pulmonary tuberculosis. Tubercle (1924) 5:217–32. doi: 10.1016/S0041-3879(24)80019-3
44. Opie EL. Pathology of the tuberculosis of childhood and its bearing on clinical work. Br Med J. (1927) 2:1130–5. doi: 10.1136/bmj.2.3493.1130
45. Esmail H, Lai RP, Lesosky M, Wilkinson KA, Graham CM, Coussens AK, et al. Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography. Nat Med. (2016) 22:1090–3. doi: 10.1038/nm.4161
46. Martinot AJ. Microbial offense vs host defense: who controls the tb granuloma? Vet Pathol. (2018) 55:14–26. doi: 10.1177/0300985817705177
47. Robertson BD, Altmann D, Barry C, Bishai B, Cole S, Dick T, et al. Detection and treatment of subclinical tuberculosis. Tuberculosis (2012) 92:447–52. doi: 10.1016/j.tube.2012.06.004
48. Drain PK, Bajema KL, Dowdy D, Dheda K, Naidoo K, Schumacher SG, et al. Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection. Clin Microbiol Rev. (2018) 31:e00021-18. doi: 10.1128/CMR.00021-18
49. Anonymous. Consensus Meeting Report. Development of a Target Product Profile (TPP) and a Framework for Evaluation for a Test for Predicting Progression From Tuberculosis Infection to Active Disease. World Health Organization, Geneva: (WHO/HTM/TB/2017.18). Licence: CC BY-NC-SA 3.0 IGO (2017).
50. Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet (2016) 387:2312–22. doi: 10.1016/S0140-6736(15)01316-1
51. Cadena AM, Fortune SM, Flynn JL. Heterogeneity in tuberculosis. Nat Rev Immunol. (2017) 17:691–702. doi: 10.1038/nri.2017.69
52. Young M. The Top 10 Secrets of Sea View Hospital on Staten Island. New York, NY: Architecture; News (2017).
53. Divangahi M, Behr MA. Cracking the vaccine code in tuberculosis. Am J Respir Crit Care Med. (2018) 197:427–32. doi: 10.1164/rccm.201707-1489PP
54. Barry CE III, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol. (2009) 7:845–55. doi: 10.1038/nrmicro2236
55. Flynn JL, Gideon HP, Mattila JT, Lin PL. Immunology studies in non-human primate models of tuberculosis. Immunol Rev. (2015) 264:60–73. doi: 10.1111/imr.12258
56. Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Primers (2016) 2:16076. doi: 10.1038/nrdp.2016.76
57. Kunh TS. The Structure of Scientific Revolutions. Chicago, IL: Univ of Chicago Press (1966).
58. Dannenberg AM Jr. Pathogenisis of Human Pulmonary Tuberculosis. Insights from the Rabbit Model. Washington, DC: ASM Press (2006).
59. Hunter RL, Olsen M, Jagannath C, Actor JK. Trehalose 6,6'-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice. Am J Pathol. (2006) 168:1249–61. doi: 10.2353/ajpath.2006.050848
60. Basaraba RJ, Hunter RL. Pathology of tuberculosis: how the pathology of human tuberculosis informs and directs animal models. Microbiol Spectr. (2017). doi: 10.1128/microbiolspec.TBTB2-0029-2016. [Epub ahead of print].
61. North RJ, Jung YJ. Immunity to tuberculosis. Annu Rev Immunol. (2004) 22:599–623. doi: 10.1146/annurev.immunol.22.012703.104635
62. Hunter RL. On the pathogenesis of post primary tuberculosis: the role of bronchial obstruction in the pathogenesis of cavities. Tuberculosis (2011) 91(Suppl. 1):S6–10. doi: 10.1016/j.tube.2011.10.003
63. Kumar P. Adult pulmonary tuberculosis as a pathological manifestation of hyperactive antimycobacterial immune response. Clin Transl Med. (2016) 5:38. doi: 10.1186/s40169-016-0119-0
64. Dubos R, Dubos G. The White Plague. Tuberculosis, Man, and Society. Brunswick, NJ: Rutgers Univesity Press (1987).
65. Lee JY, Lee KS, Jung KJ, Han J, Kwon OJ, Kim J, et al. Pulmonary tuberculosis: CT and pathologic correlation. J Comput Assist Tomogr. (2000) 24:691–8. doi: 10.1097/00004728-200009000-00005
66. Pereira M, Gazzoni FF, Marchiori E, Irion K, Moreira J, Giacomelli IL, et al. High-resolution CT findings of pulmonary Mycobacterium tuberculosis infection in renal transplant recipients. Br J Radiol. (2016) 89:20150686. doi: 10.1259/bjr.20150686
67. Verma N, Chung JH, Mohammed TL. “Tree-in-bud sign”. J Thorac Imaging (2012) 27:W27. doi: 10.1097/RTI.0b013e31824643ae
68. Hunter RL, Armitige L, Jagannath C, Actor JK. TB research at UT-Houston–a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis. Tuberculosis (2009) 89(Suppl. 1):S18–25. doi: 10.1016/S1472-9792(09)70007-1
69. Welsh KJ, Risin SA, Actor JK, Hunter RL. Immunopathology of postprimary tuberculosis: increased T-regulatory cells and DEC-205-positive foamy macrophages in cavitary lesions. Clin Dev Immunol. (2011) 2011: 307631. doi: 10.1155/2011/307631
70. Brown RE, Hunter RL, Hwang SA. Morphoproteomic-guided host-directed therapy for tuberculosis. Front Immunol. (2017) 8:78. doi: 10.3389/fimmu.2017.00078
71. Hunter RL, Actor JK, Hwang SA, Khan A, Urbanowski ME, Kaushal D, et al. Pathogenesis and animal models of post-primary (Bronchogenic) tuberculosis, a review. Pathogens (2018) 7:19. doi: 10.3390/pathogens7010019
72. Dannenberg AM Jr, Collins FM. Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products. Tuberculosis (2001) 81:229–42. doi: 10.1054/tube.2001.0287
73. Pagel W. The reproduction of early pulmonary tuberculosis of the adult type by bronchogenic and hematogenous re-infection. J State Med XLV (1937) 45:1–11
74. Blom S, Paavolainen L, Bychkov D, Turkki R, Maki-Teeri P, Hemmes A, et al. Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis. Sci Rep. (2017) 7:15580. doi: 10.1038/s41598-017-15798-4
75. Iddawela M, Rueda OM, Klarqvist M, Graf S, Earl HM, Caldas C. Reliable gene expression profiling of formalin-fixed paraffin-embedded breast cancer tissue (FFPE) using cDNA-mediated annealing, extension, selection, and ligation whole-genome (DASL WG) assay. BMC Med Genomics (2016) 9:54. doi: 10.1186/s12920-016-0215-4